| Literature DB >> 35766666 |
Jamile Caroline Garbuglio Araujo da Silva1, Tiago Giraldi1, Carolina Matida Gontijo Coutinho1, Marco Antonio Carvalho Filho2, Dario Cecílio Fernandes1, Thiago Martins Santos1.
Abstract
OBJECTIVE: To assess whether scales of physical functional performance and the surprise question ("Would I be surprised if this patient died in 6 months?") predict life support limitations and mortality in critically ill nonsurgical patients.Entities:
Mesh:
Year: 2022 PMID: 35766666 PMCID: PMC9345583 DOI: 10.5935/0103-507X.20220011-pt
Source DB: PubMed Journal: Rev Bras Ter Intensiva ISSN: 0103-507X
Patient characteristics and differences between survivors and nonsurvivors
| Variables | Survivors (n = 56) | Nonsurvivors (n = 58) | Total (N = 114) | p value |
|---|---|---|---|---|
| Age | 52.80 ± 16.93 | 62.26 ± 14.24 | 57.6 ± 16.3 | < 0.0001 |
| Sex male | 43 (76.8) | 25 (43.1) | 68 (59.7) | |
| IMV | 40 (71.4) | 53 (91.4) | 93 (81.6) | |
| ICU in days | 14.1 ± 17.3 | 13.5 ± 11.8 | 14.0 ± 15.6 | |
| Reason for admission | ||||
| Sepsis | 30 (53.6) | 21 (36.2) | 51 (44.7) | |
| Acute respiratory failure | 6 (10.7) | 5 (8.6) | 11 (9.6) | |
| AKI | 4 (7.1) | 5 (8.6) | 9 (7.9) | |
| Cardiac arrest | 1 (1.8) | 6 (10.3) | 7 (6.1) | |
| Acute cerebrovascular disease | 3 (5.3) | 3 (5.2) | 6 (5.3) | |
| Other diseases | 12 (21.4) | 18 (31.0) | 30 (26.4) | |
| Comorbidities | ||||
| Hypertension | 23 (41.1) | 30 (51.7) | 53 (46.5) | |
| Diabetes | 17 (30.3) | 21 (36.2) | 38 (33.3) | |
| Smoking | 17 (30.3) | 21 (36.2) | 38 (33.3) | |
| Alcoholism | 10 (17.8) | 16 (27.6) | 26 (22.8) | |
| Chronic kidney disease | 3 (5.3) | 10 (17.2) | 13 (11.4) | |
| Congestive heart failure | 5 (8.9) | 7 (12.1) | 12 (10.5) | |
| Drug abuse | 6 (10.7) | 4 (6.9) | 10 (8.8) | |
| Cirrhosis | 3 (5.3) | 5 (8.6) | 8 (7.0) | |
| Acute myocardial infarction | 6 (10.7) | 1 (1.7) | 7 (6.1) | |
| Cerebrovascular diseases | 3 (5.3) | 3 (5.2) | 6 (5.3) | |
| COPD | 2 (3.6) | 3 (5.2) | 5 (4.4) | |
| Cancer | 2 (3.6) | 2 (3.4) | 4 (3.5) | |
| Prognostic scores | ||||
| APACHE II | 17.25 ± 7.92 | 24.97 ± 7.14 | 21.2 ± 8.4 | < 0.001 |
| SAPS 3 | 58.14 ± 13.32 | 72.93 ± 14.63 | 65.7 ± 15.8 | < 0.001 |
| SOFA | 6.45 ± 3.77 | 9.50 ± 3.71 | 8.0 ± 4.0 | 0.0001 |
| Charlson | 2.79 ± 2.62 | 4.33 ± 2.51 | 3.6 ± 2.7 | 0.0007 |
| Performance scales | ||||
| PaP | 2.5 ± 1.5 | 3 ± 3.6 | 2.5 ± 2.9 | 0.0054 |
| KPS | 70 ± 20.9 | 60 ± 23.0 | 60 ± 22.5 | 0.0242 |
| ADL | 6 ± 1.0 | 6 ± 1.7 | 6.0 ± 1.4 | 0.0041 |
| Negative response to SQ | 13 (23.2) | 44 (75.8) | 57 (50.0) |
Patient characteristics and differences between full medical treatment and life support limitation
| Variables | FMT (n = 71) | LSL (n= 43) | Total (N = 114) | p value |
|---|---|---|---|---|
| Age | 55.93 ± 17.10 | 60.40 ± 14.51 | 57.6 ± 16.3 | 0.0106 |
| Sex male | 41 (57.7) | 27 (62.8) | 68 (59.7) | |
| IMV | 54 (76.0) | 39 (90.7) | 93 (81.6) | |
| ICU in days | 13.4 ± 17.04 | 14.7 ± 12.6 | 14.0 ± 15.6 | |
| ICU survival | 58 (81.7) | 19 (44.2) | 77 (67.5) | |
| Reason for admission | ||||
| Sepsis | 38 (53.5) | 13 (30.2) | 51 (44.7) | |
| Acute respiratory failure | 9 (12.7) | 2 (4.6) | 11 (9.6) | |
| AKI | 6 (8.4) | 3 (7.0) | 9 (7.9) | |
| Cardiac arrest | 3 (4.2) | 4 (9.3) | 7 (6.1) | |
| Acute cerebrovascular disease | 3 (4.2) | 3 (7.0) | 6 (5.3) | |
| Other diseases | 12 (10.6) | 18 (41.9) | 30 (26.4) | |
| Comorbidities | ||||
| Hypertension | 31 (27.2) | 22 (51.2) | 53 (46.5) | |
| Diabetes | 23 (20.2) | 15 (34.9) | 38 (33.3) | |
| Smoking | 25 (21.9) | 13 (30.2) | 38 (33.3) | |
| Alcoholism | 15 (13.1) | 11 (25.6) | 26 (22.8) | |
| Chronic kidney disease | 6 (16.9) | 7 (16.3) | 13 (11.4) | |
| Congestive heart failure | 6 (16.9) | 6 (14.0) | 12 (10.5) | |
| Drug abuse | 7 (9.8) | 3 (7.0) | 10 (8.8) | |
| Cirrhosis | 5 (7.0) | 3 (7.0) | 8 (7.0) | |
| Acute myocardial infarction | 5 (7.0) | 2 (4.7) | 7 (6.1) | |
| Cerebrovascular diseases | 3 (4.2) | 3 (7.0) | 6 (5.3) | |
| COPD | 3 (4.2) | 2 (4.7) | 5 (4.4) | |
| Cancer | 2 (2.8) | 2 (4.7) | 4 (3.5) | |
| Prognostic scores | ||||
| APACHE II | 19.31 ± 8.31 | 24.26 ± 7.81 | 21.2 ± 8.4 | 0.0054 |
| SAPS 3 | 62.32 ± 15.29 | 71.19 ± 15.22 | 65.7 ± 15.8 | 0.0057 |
| SOFA | 7.51 ± 4.34 | 8.81 ± 3.35 | 8.0 ± 4.0 | 0.0971 |
| Charlson | 3.11 ± 2.46 | 4.33 ± 2.84 | 3.6 ± 2.7 | 0.0368 |
| Performance scales | ||||
| PaP | 2.5 ± 2.2 | 3.5 ± 3.6 | 2.5 ± 2.9 | 0.0018 |
| KPS | 80 ± 21.2 | 60 ± 23.4 | 60 ± 22.5 | 0.0192 |
| ADL | 6 ± 1.1 | 6 ± 1.7 | 6.0 ± 1.4 | 0.0115 |
| Negative response to SQ | 17 (23.9) | 40 (93.0) | 57 (50.0) |
Life support limitations
| Crude analysis | Adjusted analysis† | |||
|---|---|---|---|---|
| OR (95%CI) | p value | OR (95%CI) | p value | |
| KPS | 1.02 (1.0 - 1.04) | 0.01 | 1.02 (1.0 - 1.04) | 0.08 |
| PaP | 0.98 (0.95 - 1.01) | 0.3 | 0.97 (0.95 - 1.02) | 0.45 |
| ADL | 1.35 (1.01 - 1.78) | 0.04 | 1.34 (1.0 - 1.79) | 0.05 |
| SQ | 42.35 (11.62 - 154.43) | 0.00 | 47.79 (11.41 - 200.25) | 0.00 |
Univariate analysis; †multivariable analysis adjusted for the Simplified Acute Physiology Score 3 score, Charlson score, and age.
Hospital mortality
| Crude analysis | Adjusted analysis | |||
|---|---|---|---|---|
| OR (95%CI) | p value | OR (95%CI) | p value | |
| KPS | 1.02 (1.0 - 1.04) | 0.01 | 1.02 (0.99 - 1.04) | 0.15 |
| PaP | 0.94 (0.86 - 1.02) | 0.13 | 0.94 (0.86 - 1.03) | 0.17 |
| ADL | 1.49 (1.04 - 2.09) | 0.03 | 1.58 (1.10 - 2.26) | 0.01 |
| SQ | 10.4 (4.38 - 24.66) | 0.00 | 6.17 (2.43 - 15.64) | 0.00 |
Univariable analysis.